Boston Scientific and Blackstone agree on $455m VITALYST heart pump deal
Boston Scientific and Blackstone Life Sciences (BXLS) have entered a $455m co-funding collaboration for the VITALYST heart pump programme.
The post Boston Scientific and Blackstone agree on $455m VITALYST heart pump deal appeared first on Medical Device Network .